{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreihn4nfrqlwqbt2q5lst33hvvxtjmvaqliyxlyse7xnm7fd435wece",
    "uri": "at://did:plc:k7h5fn3kdhjpj37pc6yhno2o/app.bsky.feed.post/3mf6f54kmhso2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreihkb6lz7u5spekky2qi3nbgmhmk4zzyuxv367khaygracnvh67oii"
    },
    "mimeType": "image/jpeg",
    "size": 64582
  },
  "path": "/article/why-the-fda-is-cracking-down-on-compound-glp-1-drugs-for-weight-loss/",
  "publishedAt": "2026-02-18T13:00:00.000Z",
  "site": "https://www.scientificamerican.com",
  "textContent": "The recent withdrawal of Hims & Hers’ GLP-1 pill raises questions about the safety and effectiveness of compounded medications",
  "title": "Why the FDA is cracking down on compound GLP-1 drugs for weight loss"
}